Investigation of the veins in patients with Behçet’s disease with no known vascular event by Doppler ultrasonography
Tóm tắt
In Behçet’s disease, deep venous thrombosis occurs primarily in the lower extremities. Total recanalization rate is low, so thrombotic segment could be detected by imaging afterward. For disclosing vein involvement, leg swelling is commonly queried in the history taking in those patients. However, there are no data about the presence of “silent” thrombosis in patients with BD. We aimed at investigating the integrity of venous vessels in BD, without any known vascular event by using Doppler ultrasonography (DU). Patients having past events revealed in the vascular questionnaire or physical findings attributable to vascular disease were excluded. Various degree of venous insufficiency was detected in 74 patients in BD (74%), 24 out of 33 patients (72%) in AS and in 8 out of 34 (25%) in HC group. All were at the lower extremities, and there is no difference in the frequency between BD and AS, while both were significantly higher than in HC (P = 0.001, and 0.004, respectively). Six patients with BD (6%) have chronic venous thrombi at the lower extremities and none in either AS and HC. As a non-invasive method, DU of lower extremities may disclose “silent” thrombosis. Venous insufficiency in those patients should be considered cautiously as an indicator of vein involvement.
Tài liệu tham khảo
Sakane T, Takeno M, Suzuki N et al (1999) Behcet’s disease. New Engl J Med 341:1284–1291
Lawall H, Hoffmanns W, Hoffmanns P et al (2007) Prevalence of deep vein thrombosis (DVT) in non-surgical patients at hospital admission. Thromb Haemost 98:765–770
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
Labropoulos N, Tiongson J, Pryor L et al (2003) Definition of venous reflux in lower-extremity veins. J Vasc Surg 38:793–798
Herman RJ, Neimen HL, Yao JST et al (1980) Descending venography: a method of evaluating lower extremity venous valvular function. Radiology 137:63–69
Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
Kearon C, Julian JA, Newman TE et al (1998) Noninvasive diagnosis of deep venous thrombosis. McMaster diagnostic ımaging practice guidelines ınitiative. Ann Intern Med 128:663–677
Düzgün N, Ateş A, Aydintuğ OT et al (2006) Characteristics of vascular involvement in Behçet’s disease. Scand J Rheumatol Jan-Feb 35(1):65–68
Hampton KK, Chamberlain MA, Menon DK et al (1991) Coagulation and fibrinolytic activity in Behcet’s disease. Thromb Haemost 66:292–294
Gul A, Aslantas AB, Tekinay T, Konice M, Ozcelik T et al (1999) Procoagulant mutations and venous thrombosis in Behcet’s disease. Rheumatology 38:1298–1299
Ozoran K, Duzgun N, Gurler A et al (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behcet’s disease. Scand J Rheumatol 24:376–382
Fresko I, Melikoglu M, Tunc R et al (2002) Behcet’s syndrome: pathogenesis, clinical manifestations and treatment in Vasculitis by Gene V. Ball, S. Louis Bridgesed, 1st edn. Oxford University Press, USA
Kuzu A, Köksoy C, Ozaslan C et al (1996) Evaluation of peripheral vascular system disorders in vascular symptom—free Behçet’s disease. Cardiovasc Surg Jun 4(3):381–383
Heidrich H, Konau E, Hesse P (2009) Asymptomatic venous thrombosis in cancer patients–a problem often overlooked. Results of a retrospective and prospective study. Vasa 38(2):160–166
Verlato F, Bruchi O, Prandoni P et al (2001) Investigators group. Warfarin optimal duration orthopaedic study. The value of ultrasound screening for proximal vein thrombosis after total hip arthroplasty—a prospective cohort study. Thromb Haemost 86(2):534–537